Researchers at Michigan State University and Henry Ford Health received a $3 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases within the National Institutes of Health to study the connections between maternal body mass index, or BMI, and childhood obesity.
Regeneron’s Veopoz scores FDA approval for rare immune disease – Pharmaceutical Technology
Veopoz’s approval was based on the data from the open-label Phase II/III trial (NCT04209634) consisting of ten participants. Image Credit: lev radin / Shutterstock. Regeneron
August 21, 2023